JARED KNIGHTING: Open Payments
NPI 1790481604 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,238 in 137 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $1,821 · 2025 $3,238
Food & beverage: $3,238
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 16 | $503 |
| Vanda Pharmaceuticals Inc. | 15 | $451 |
| Janssen Pharmaceuticals, Inc | 10 | $348 |
| Neurocrine BioSciences, Inc. | 14 | $320 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $304 |
| ABBVIE INC. | 20 | $284 |
| Corium, LLC | 12 | $262 |
| Otsuka America Pharmaceutical, Inc. | 8 | $260 |
| Tris Pharma Inc | 11 | $173 |
| E.R. Squibb & Sons, L.L.C. | 8 | $136 |
Products named: FANAPT, INGREZZA, CAPLYTA, ARISTADA, VRAYLAR, Azstarys, REXULTI, SPRAVATO.
Industry payments across AL — which companies pay providers there.
